861857-49-0

Basic information

• Product Name: Benzonitrile, 5-(2,2-dimethylpropyl)-2-(1H-imidazol-1-yl)-
• CAS NO: 861857-49-0
• Molecular Formula: C15H17N3
• Molecular Weight: 239.32
• Mol File: 861857-49-0.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: Benzonitrile, 5-(2,2-dimethylpropyl)-2-(1H-imidazol-1-yl)-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzonitrile, 5-(2,2-dimethylpropyl)-2-(1H-imidazol-1-yl)-(861857-49-0)
• EPA Substance Registry System: Benzonitrile, 5-(2,2-dimethylpropyl)-2-(1H-imidazol-1-yl)-(861857-49-0)

Safety Data

• Hazardous Substances Data: 861857-49-0(Hazardous Substances Data)

Upstream product

• 530080-31-0 5-bromo-2-(1H-imidazol-1-yl)benzonitrile 
• 15501-33-4 neopentyl iodide 
• 262422-94-6 2,2-dimethylpropyl zinc iodide 
• 288-32-4 1H-imidazole 
• 861857-65-0 5-neopentyl-2-fluoro-1-yl-benzonitrile 

Relevant articles and documents

Methods of treatment of amyloidosis using bi-aryl aspartyl protease inhibitors

The invention relates to novel compounds and methods of treating diseases, disorders, and conditions associated with amyloidosis. Amyloidosis refers to a collection of diseases, disorders, and conditions associated with abnormal deposition of A-beta protein.

METHODS OF TREATMENT OF AMYLOIDOSIS USING ASPARTYL-PROTEASE INHIBITORS

The invention relates to acetyl 2-hydroxy-1,3-diaminospirocyclohexanes and derivatives thereof that are useful in treating diseases, disorders, and conditions associated with amyloidosis. Amyloidosis refers to a collection of diseases, disorders, and conditions associated with abnormal deposition of A-beta protein.

SUBSTITUTED HYDROXYETHYLAMINE ASPARTYL PROTEASE INHIBITORS

The invention relates to novel compounds and also to methods of treating at least one disease, disorder, or condition associated with amyloidosis using such compounds. Amyloidosis refers to a collection of diseases, disorders, and conditions associated with abnormal deposition of A-beta protein.